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Abstract
Aims/hypothesis Pancreatic beta cells maintain glucose
homeostasis and beta cell dysfunction is a major risk factor
in developing diabetes. Therefore, understanding the develop-
mental regulatory networks that define a fully functional beta
cell is important for elucidating the genetic origins of the dis-
ease. Aldehyde dehydrogenase activity has been associated
with stem/progenitor cells and we have previously shown that
Aldh1b1 is specifically expressed in pancreas progenitor
pools. Here we address the hypothesis that Aldh1b1 may reg-
ulate the timing of the appearance and eventual functionality
of beta cells.
Methods We generated an Aldh1b1-knockout mouse line
(Aldh1b1tm1lacZ) and used this to study pancreatic develop-
ment, beta cell functionality and glucose homeostasis in the
absence of Aldh1b1 function.
Results Differentiation in the developing pancreas of
Aldh1b1tm1lacZ null mice was accelerated. Transcriptome
analyses of newborn and adult islets showed misregulation of
key beta cell transcription factors and genes crucial for beta cell
function. Functional analyses showed that glucose-stimulated
insulin secretion was severely compromised in islets isolated
from null mice. Several key features of beta cell functionality
were affected, including control of oxidative stress, glucose
sensing, stimulus-coupling secretion and secretory granule
biogenesis. As a result of beta cell dysfunction, homozygous
mice developed glucose intolerance and age-dependent
hyperglycaemia.
Conclusions/interpretation These findings show that
Aldh1b1 influences the timing of the transition from the pan-
creas endocrine progenitor to the committed beta cell and
demonstrate that changes in the timing of this transition lead
to beta cell dysfunction and thus constitute a diabetes risk
factor later in life.
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Extensive genome-wide association studies have identified
over 80 genomic susceptibility loci for type 2 diabetes. The
majority of the discovered risk variants have been linked to
beta cell dysfunction rather than to insulin resistance [1].
Thus, elucidating the developmental regulatory networks
defining a fully functional beta cell is important for under-
standing the genetic origins of the disease and derivingmature
beta cells from stem cells.
All pancreatic cell types are derived from progenitors that
emerge at the posterior foregut region of the definitive endo-
derm and expand to form a branched epithelium surrounded by
mesenchyme [2]. Subsequently, acinar progenitors are con-
fined at the tips, while trunk cells become endocrine/duct
bipotent progenitors. Neurogenin 3-positive (NGN3+) endo-
crine progenitors arise in the trunk and migrate into the mesen-
chyme leaving behind ductal progenitors [3]. The emergence
of progenitor pools and differentiated cell types is temporally
regulated but the mechanisms implicated are unknown [3, 4].
After birth, normal beta cell development continues with the
maturation of the stimulus–secretion coupling machinery, the
enhancement of glucose sensing, the increase in the number of
insulin-containing secretory granules (SGs) and the establish-
ment of the appropriate beta cell mass through extensive pro-
liferation. Several transcription factors implicated in progenitor
and endocrine specification also play key overlapping roles in
the postnatal expansion, maturation and maintenance of adult
beta cells. Their expression levels are also important for beta
cell functionality [5–12]. Disturbances of the intrauterine mi-
lieu can lead to islet defects and diabetes later in life but little is
known about the molecular mediators of this effect [13–15].
Aldehyde dehydrogenase (ALDH) activity is increasingly
associated with stem/progenitor cells and it is hypothesised
that it contributes to the maintenance of the progenitor status
[16–19]. Mitochondrial Aldh1b1 is specifically expressed in
all pancreas progenitors in the mouse embryo but not in ma-
ture endocrine cells. Its expression in the adult is confined to
rare centroacinar-like cells with pancreas stem/progenitor
characteristics [18, 20]. Here we addressed the hypothesis that
Aldh1b1 may regulate the timing of the appearance and even-
tual functionality of beta cells.
Methods
A l dh 1 b 1 t m 1 l a c z - k n o c k - i n mou s e s t r a i n The
Aldh1b1tm1(KOMP)Vlcg ES line (KOMP; UC Davis, CA, USA)
was used to generate the Aldh1b1tm1lacZ allele (electronic sup-
plementary material [ESM] Fig. 1). Animal maintenance and
experimentation were in accordance with international guide-
lines and subjected to ethics approval from the competent
veterinary committees of Athens and TU Dresden. Animals
were assigned to experiments randomly on condition of ful-
filling the conditions of the experiment (genotype, sex, age)
as described, and the scoring/outcome assessment was blind
to group assignment.
Fasting glucose measurements and glucose, insulin and
pyruvate tolerance tests For the intraperitoneal glucose
tolerance test (IPGTT), male mice were fasted for 16 h
overnight and injected intraperitoneally with D-glucose
(Sigma-Aldrich, St Louis, MO, USA) at 2 g/kg. Blood from
the tail vein was used to determined glucose level using the
Contour XT monitoring system (Bayer, Leverkusen,
Germany) and insulin level was determined in the supernatant
fraction following clotting using an ultrasensitive mouse insu-
lin ELISA kit (Mercodia, Uppsala, Sweden). Details of the
intraperitoneal insulin tolerance test (IPITT) and intraperito-
neal pyruvate tolerance test (IPPTT) procedures are provided
in ESM Methods.
Immunostaining and morphometric analysis Dissected
pancreases were fixed in 4% wt/vol. paraformaldehyde and
processed for immunofluorescence using standard procedures
[18, 21]. Details of antibodies used and morphometric analy-
ses are provided in ESM Methods.
Islet isolation and functional analyses Islets were isolated
from male mice and maintained as described [22]. Standard
procedures were used for insulin secretion assays, measure-
ments of intracellular calcium ([Ca2+]i) changes [23], detec-
tion of reactive oxygen species (ROS) [24], ATP measure-
ments [25] and transmission electron microscopy [26].
Details are provided in ESM Methods.
RNA isolation, real-time PCR, RNA Seq and accession
numbers Total RNA was prepared using the RNeasy kit
(Qiagen, Hilden, Germany), first-strand cDNA preparation,
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real-time PCR and library preparations for RNA sequencing and
bioinformatics analyses were done according to standard proce-
dures. Details are provided in ESMMethods. Raw and normal-
ised data were deposited in GEO (www.ncbi.nlm.nih.gov/geo)
under accession number GSE58025.
Hormone measurements and liver glycogen content assay
Pancreatic insulin, proinsulin and glucagon content, as well as
liver glycogen content, were assayed as described in ESM
Methods.
Western blotting and X-gal stainingDetails on western blot-
ting and X-gal staining procedures are provided in ESM
Methods.
Statistical analyses Statistical significance was determined
by Student’s t test for two-tailed distributions of unpaired
groups. For analyses of wild-type and null mice at different
time points (with the exception of gestation time points) two-
way ANOVA with Bonferroni post hoc test for differences
between means were conducted. The SEM is provided unless
otherwise stated and p<0.05 was considered significant. For
differences in islet size distributions and means, statistical sig-
nificance was determined using the Wilcoxon rank-sum test
and p<0.001 was considered significant.
Results
Premature lineage commitment during development in
the absence of Aldh1b1 expression We generated the
Aldh1b1tm1lacZ mouse line (ESM Fig. 1 a, b) and analysed
pancreas development in the Aldh1b1tm1lacZ null embryos in
which Lacz expression recapitulated expression in the pancre-
as (ESM Fig. 1 c–h).
Early development appeared normal (data not shown) but
progenitor differentiation was accelerated during the secondary
transition. There was a transient increase in the number of
NGN3+ cells at 13.5 and 14.5 days post coitum (dpc)
(Fig. 1a, b, k) and, consistently, the number of C-peptide-
positive (C-PEP+) cells (but not glucagon-positive [GCG+] cells,
data not shown) was increased in the Aldh1b1tm1lacZ null
pancreases (Fig. 1c, d, k). Amylase complex-positive (AMY+)
acinar cells and duct Dolichos biflorus agglutinin-positive
(DBA+) cells appeared earlier and were more numerous in the
Aldh1b1tm1lacZ null pancreases at 14.5 dpc (Fig. 1e–h, l, m).
The number of epithelial cells in mitosis (Phosphohistone-
H3+/E-cadherin+ cells) transiently increased in the
Aldh1b1tm1lacZ null pancreases at 14.5 dpc, thus compensating
for the accelerated differentiation and maintaining the size of
the organ (Fig. 1k and data not shown). Apoptosis levels,
detected by immunofluorescence for activated caspase-3,
Fig. 1 ALDH1B1 controls timing of commitment and proliferation of
embryonic pancreas progenitors and is expressed in nascent beta cells.
(a–h) The number of NGN3+ (a, b), C-PEP+ (c, d), AMY+ (e, f) and
DBA+ (g, h) cells was increased in pancreases ofAldh1b1tm1lacZ null mice
compared with wild-type mice. (i, j) Co-expression of ALDH1B1 with
newly formed beta cells remains until 15.5 dpc (arrows) but is lost at
16.5 dpc. (k) Quantification of C-PEP+ (squares), NGN3+ (triangles)
signal (DAPI normalised) and number of PH3+ epithelial (diamonds)
cells per islet at 13.5, 14.5 and 15.5. dpc showed a transient increase
(expressed as fold increase compared with wild-type) in Aldh1b1tm1lacZ
null pancreases. Comparisons were done for the same day. (l, m) Quan-
tification of AMY+ (l) and DBA+ (m) signal (DAPI normalised) at
14.5 dpc showed a strong increase (expressed as ratio over wild-type)
in the Aldh1b1tm1lacZ null pancreases (black bars, wild-type; grey bars,
null). Results are from four to six embryos per genotype and per embry-
onic stage, and values are representative of eight sections per embryonic
pancreas spanning the entire organ. *p<0.05 and **p<0.01. Scale bars,
50 μm (a, b), 100 μm (c, d), 20 μm (e–h) and 15 μm (i, j). E-CAD,
E-cadherin
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were very low and similar to controls excluding implication of
ALDH1B1 in progenitor survival (data not shown).
Expression of the sex determining region Y-box 9 (SOX9),
pancreatic and duodenal homeobox 1 (PDX1) and pancreas
specific transcription factor 1a (PTF1a) progenitor markers at
14.5 dpc and RNA Seq analysis of 13.5 and 15.5 dpc total
pancreases did not detect other significant quantifiable differ-
ences between wild-type and Aldh1b1tm1lacZ null pancreases,
suggesting that only a subset of progenitor cells are affected at
successive time points. Careful analysis of ALDH1B1 expres-
sion showed that the protein persisted in nascent C-PEP+ cells
until 15.5 dpc but not later (Fig. 1i, j and data not shown).
Therefore, loss of Aldh1b1 function resulted in premature
differentiation, balanced by increased mitosis, suggesting a
dual role for Aldh1b1 in regulating both timing of commit-
ment and proliferation of progenitors. We then asked whether
loss of ALDH1B1 in progenitors and nascent beta cells affect-
ed islet patterning and beta cell function.
Islet patterning is defective in newbornAldh1b1tm1lacZ null
mice Cellular analysis revealed a striking heterogeneity of
Aldh1b1tm1lacZ null islets at postnatal day 1 (P1). Expression
of the transcription factors PDX1 and NK6 homeobox
1 (NKX6.1) [12, 27–30] was homogeneous in control islets
whereas a large number of Aldh1b1tm1lacZ null islets showed
absent, substantially weaker NKX6.1 expression (47%) or
strongly increased expression (18%). Some (35%) showed
substantially weaker PDX1 expression compared with con-
trols and co-expression of NKX6.1 and PDX1 within cells
of the same islet was not uniform (ESM Fig. 2 a, b, b’ and
data not shown) (n=76). This was accompanied by variable
levels of C-PEP immunofluorescence in the Aldh1b1tm1lacZ
null P1 pancreases, where 50% of the islets had either reduced
or absent staining compared with controls (ESM Fig. 2c, d, d’).
In addition, the number of phosphohistone-H3 (PH3)+ cells
was increased by nearly 40% in the null islets (ESM Fig. 2f
and data not shown). However, Aldh1b1tm1lacZ P1 null
pancreases had similar weight, beta cell mass, islet size distri-
bution and insulin, proinsulin and glucagon content compared
with controls. The relative numbers of alpha, beta and delta
cells remained similar (Fig. 4d, ESM Figs 2 e, 3 g–j, l and data
not shown).
Western blots and RNA Seq data confirmed that Aldh1b1 is
not expressed in the islets at postnatal and adult stages [18]
(ESM Fig. 2g). Transcriptome comparison of P1
Aldh1b1tm1lacZ null and control islets showed deregulation of a
substantial number of genes (Fig. 2a, c). This deregulation in-
cluded repression of several transcription factors with key roles
in beta cell maturation and maintenance, such as Pdx1, Nkx6.1,
Mafa andMafb (Fig. 2d and ESMTable 1), andmisregulation of
several genes encoding vesicular and SG proteins (see below).
Taken together these data suggest thatAldh1b1 is necessary
for proper fetal development of beta cells and the upregulation
of key transcription factors.
Islet patterning defects are maintained and expanded in
adulthood The murine pancreas undergoes dramatic remod-
elling during the postnatal period when beta cell mass expands
and beta cells acquire the capacity to secrete insulin in response
to glucose [31, 32]. Heterogeneity in Aldh1b1tm1lacZ null islets
persisted in early adults at 6 weeks of age. Nearly one-third of
null islets (30%) showed substantially lower or absent expres-
sion of both PDX1 and NKX6.1, one-third (37%) consisted of
a mixture of PDX1+ and NKX6.1+ cells and the remaining
33% had normal PDX1 and NKX6.1 expression (n=123)
(Fig. 3a–c, k). Changes in the expression of these genes have
been associated with increased numbers of GCG+ and somato-
statin (SOM)+ cells [12, 25]. Accordingly, many null islets
contained supernumerary GCG+ and SOM+ cells and often
had disrupted architecture (Fig. 3d–g). There was no apparent
interconversion among endocrine cells since we were unable to
detect any C-PEP+/GCG+ or insulin-positive (INS)+/SOM+
cells (data not shown). Furthermore, 50% of the islets, particu-
larly larger ones, had low or even absent C-PEP and INS
Fig. 2 Islet transcriptome analysis at P1 and week 8 (WK 8). (a, b) Scatter
plots of normalised gene transcription counts (cts) of Aldh1b1tm1lacZ null
islets vs wild-type (WT) islets at P1 (a) (Pearson’s r=0.63) and WK 8 (b)
(Pearson’s r=0.56). Diagonal lines represent regulation cut-offs at 0.6- and
1.6-fold. (c) Proportional Venn diagram of the genes misregulated in
Aldh1b1tm1lacZ null islets at P1, WK 8 or both (overlap). In the overlap,
the direction of regulation at P1 (left) or WK 8 (right) is shown for genes
regulated at both time points. (d) Heat map of relative expression values
(z scores) of transcription factors in Aldh1b1tm1lacZ null and control
pancreases at P1 and WK 8. *padj≤0.1: at the left side of the heat map
* refers to comparisons at P1 whereas at the right side it refers to compar-
isons at WK 8
142 Diabetologia (2016) 59:139–150
immunoreactivity while maintaining normal GLUT2 and
glucagon-like peptide-1 receptor (GLP1R) expression
(Fig. 3h–j and ESM Fig. 4 a–d). Null islets showed ectopic
caspase-3 immunoreactivity in both normally and weakly
C-PEP+ null islets (Fig. 3l, m) and persistent mitotic activity,
mostly in those exhibiting low C-PEP staining (Fig. 3n, o), thus
maintaining beta cell mass and median islet size (Fig. 4d and
ESM Fig. 3a). Heterogeneity persisted at week 20, particularly
concerning low C-PEP and NKX6.1 immunofluorescence,
mostly in larger islets (ESM Fig. 4 e–h).
These findings showed that defects and heterogeneity in
islet patterning persisted into adulthood and to determine their
extent we compared the transcriptome of Aldh1b1tm1lacZ null
and control islets isolated at week 8. The number of
misregulated genes had now expanded more than sixfold
(Fig. 2b, c) and gene ontology analyses suggested that key
components of beta cell function were affected (see below).
Strikingly, expression of most transcription factors necessary
to maintain islet functionality, with the notable exception of
the downregulation of Nfe2l2 (Nrf2), a gene protecting beta
cells from oxidative stress [33], was upregulated, suggesting
an effort towards functional compensation (Fig. 2d and ESM
Table 1). Consistent with the increased mitosis rates, expres-
sion of several cell cycle and mitosis-associated genes was
altered in the Aldh1b1tm1lacZ null islets (ESM Fig. 5a and
ESM Table 2). Continued mitosis in the islets resulted in a
3.6-fold expansion of the beta cell mass and a twofold increase
in the median islet size in Aldh1b1tm1lacZ nulls by week 20
(Fig. 4a–d, ESM Fig. 2e and ESM Fig. 3a).
These findings showed that early defects persisted and ex-
panded in the islets of Aldh1b1tm1lacZ null mice, suggesting
impaired functionality.
Nullmice are glucose intolerant and develop age-dependent
hyperglycaemia To establish whether these molecular defects
compromised glucose homeostasis we first determined blood
glucose levels following overnight fasting of 6- to 52-week-old
mice. From 12 weeks onwards Aldh1b1tm1lacZ null mice devel-
oped hyperglycaemia, which accelerated with age (Fig. 4e)
[34]. IPGTTs showed that the onset of hyperglycaemia was
Fig. 3 Islet patterning defects in Aldh1b1tm1lacZ null young adult mouse
islets. (a–c, h–i) Substantially lower (b) or absent (c) PDX1, NKX6.1
(a–c) and C-PEP (h, i) expression in Aldh1b1tm1lacZ null islets. (d–g)
Quantitative analysis of glucagon (GCG) and SOM (d, e) signal per islet
(expressed as ratio of signal over DAPI signal) shows that the signal is
increased by 60 and 65%, respectively (f, g), in Aldh1b1tm1lacZ null islets
(black bars, wild-type; grey bars, null). (j, k) Quantitative analysis of
C-PEP signal (j) and PDX1+, NKX6.1+ cells (k) per islet (expressed as
ratio of signal over DAPI signal) shows that their expression is signifi-
cantly reduced in Aldh1b1tm1lacZ null islets (black bars, wild-type; grey
bars, null). (l, m) Aldh1b1tm1lacZ null islets showed increased levels of
apoptosis as indicated by double immunofluorescence for caspase-3
(CASP-3) and either insulin (INS) (l) or GCG (m) (arrows). (n, o)
Immunofluorescence for PH3 (n) indicated that mitotic activity was
50-fold higher (o) in Aldh1b1tm1lacZ null islets (black bars, wild-type; grey
bars, null). Results are from three to five animals per genotype, and values
are representative of scoring at least 50 islets spanning the entire pancreas
of each animal. Values are mean±SEM. ***p<0.001 for indicated com-
parisons. Scale bars, 25 μm (a–e, h, i, l–n). TF, transcription factor
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preceded by reduced glucose tolerance and significant delay in
acute insulin secretion in young adult Aldh1b1tm1lacZ null mice.
The first-phase response in the Aldh1b1tm1lacZ null mice took
nearly three times as long to peak without reaching control
levels and a second-phase response was absent (Fig. 4f, g).
Reduced glucose tolerance was further exacerbated at week
20 and acute insulin secretion was equally weak at week 20
(ESM Fig. 3b, c).
Hormone levels were not reduced at week 8 or week 20 in
Aldh1b1tm1lacZ null pancreases and pancreas weight was similar
to that in wild-type controls (see above and data not shown). In
fact, there was a transient increase in insulin and proinsu-
lin content as well as a 2.6-fold increase in glucagon con-
tent in the null pancreases at week 8 (ESM Fig. 3j). The
insulin-to-proinsulin ratio remained remarkably similar
between Aldh1b1tm1lacZ null and controls until week 20
(ESM Fig. 3g–i). Total pancreas hormone levels returned to
normal at week 20 and this, coupled with the 3.6-fold expan-
sion in beta cell mass at that stage (ESM Figs 3g, h, j and
Fig. 4d), implied lower insulin concentration in cells.
ALDH1B1 is not expressed in the fat or skeletal mus-
cle of adult mice, as demonstrated by the lack of detect-
able β-galactosidase activity in Aldh1b1tm1lacZ heterozygotes
(data not shown). To exclude the possibility that the defects in
glucose homeostasis observed in Aldh1b1tm1lacZ null mice are
due to secondary defects arising from the liver or other
peripheral tissues, we conducted a series of experiments
that included IPITTs (ESM Fig. 3d), measurement of glu-
cagon levels in the blood (ESM Fig. 3l), IPPTTs and mea-
surement of glucose-6-phosphatase gene transcript levels as
indicators of gluconeogenesis (ESM Fig. 3m, n), and measure-
ment of hepatic glycogen stores (ESM Fig. 3m). In all assays,
Aldh1b1tm1lacZ null mice behaved similarly to wild-type
controls.
Taken together, these findings suggested that the
Aldh1b1tm1lacZ null mice are glucose intolerant due to
islet defects in glucose-stimulated insulin secretion
(GSIS).
Aldh1b1 tm1lacZ null islets are defective in GSIS
Aldh1b1tm1lacZ null mice are born with islet molecular defects
that are expanded in early adulthood. The high insulin content
in the pancreases of adult Aldh1b1tm1lacZ null mice at week 8
(ESM Fig. 3g) partially compensated for functional defects
and delayed the onset of hyperglycaemia, which became evi-
dent from week 12 and worsened progressively with age
(Fig. 4e). Therefore, we focused subsequent functional analy-
ses of the islets at week 20. Serum insulin levels were similar
Fig. 4 Aldh1b1tm1lacZ null mice have larger islets but are glucose intol-
erant and develop age-dependent hyperglycaemia. (a, b) Double immu-
nofluorescence for C-PEP and glucagon (GCG) indicated the presence of
both normal-sized islets (arrowheads) and significantly larger islets
(arrows) in Aldh1b1tm1lacZ null mice compared with wild-type mice. (c)
Morphometric analysis and plotting of the islet size probability density
function (pdf) illustrates the significantly larger Aldh1b1tm1lacZ null me-
dian islet size (3,223) compared with the wild-type (1,413) (black line,
wild-type; grey line, null) at week 20. Sizes are expressed in pixels
(100 μm=135 pixels). Differences in the distribution are significant
(p<0.001). (d) Beta cell mass differences are negligible at P1 and week
6 (WK 6) but there is a 3.6-fold increase in the beta cell mass of the
Aldh1b1tm1lacZ compared with that of wild-type at week 20 (WK 20)
(black bars, wild-type; grey bars, null). **p<0.01 for the indicated
comparison. (e) Blood glucose levels after overnight fasting in 6- to
52-week-old mice showed that Aldh1b1tm1lacZ nulls gradually develop
hyperglycaemia (black line, wild-type; grey line, null) (n=8–20).
(f) Aldh1b1tm1lacZ nulls show a significant delay in blood glucose clear-
ance during IPGTT at week 8 (n=8, 7) (black line, wild-type; grey line,
null). (g) Acute insulin secretion during IPGTT is impaired at WK 8 in
Aldh1b1tm1lacZ null mice compared with wild-type mice (n=5)
(black line, wild-type; grey line, null). Results in (a–d) are from three
animals per genotype and per age group, and values are representative of
25 sections spanning the entire pancreas of each animal. Results in (e–g)
are from the indicated number of animals (n) per genotype. Values are
mean±SEM. *p<0.05, **p<0.01 and ***p<0.001, Aldh1b1tm1lacZ null
vs wild-type. Scale bar, 1.5 mm
144 Diabetologia (2016) 59:139–150
in Aldh1b1tm1lacZ null and control mice, following a 4 h
fasting period (ESM Fig. 3k) but following a glucose chal-
lenge the defects in acute insulin secretion of Aldh1b1tm1lacZ
null mice were similar to those detected at week 6 (Fig. 4g and
ESM Fig. 3c). We then directly assayed the GSIS capacity of
islets isolated from Aldh1b1tm1lacZ null mice at week 20.
Insulin medium concentration in the basal condition was
79.2±8.6 pmol/l in wild-type islets and 87.8±6.9 pmol/l in
Aldh1b1tm1lacZ null islets. Aldh1b1tm1lacZ null islets responded
very weakly to glucose (Fig. 5a), with insulin concentration
reaching 118.8±5.2 pmol/l whereas in wild-type islets it
reached 1.72±0.22 nmol/l.
These findings showed that Aldh1b1tm1lacz null islets had
severe defects in glucose sensing, stimulus-coupled insulin
secretion or both.
Glucose sensing is impaired in the Aldh1b1tm1lacZ null
islets We then investigated glucose uptake, glycolytic flux
and ATP generation in the Aldh1b1tm1lacZ null mutants.
Immunostaining for Glut2 (Slc2a2) did not reveal changes in
expression at either week 6 or week 20 (ESM Fig. 4 i, j).
However, GLP1R immunostaining was severely decreased
in all Aldh1b1tm1lacZ islets, indicating the loss of its potentiat-
ing effect in glucose uptake (Fig. 5f, g). RNASeq data showed
that expression of c-myc, a central regulator of glycolytic gene
expression [35], was strongly repressed and expressions of
several genes involved in the glycolytic pathway and genes
encoding enzymes diverting glutamine in the tricarboxylic
acid cycle were deregulated (Fig. 5e and ESM Table 1). In
mammals, low energy levels are reflected by increased
AMP:ATP or ADP:ATP ratios and this leads to the activation
of AMP-activated protein kinase (AMPK) by phosphorylation
[36]. Levels of P-AMPKA in the Aldh1b1tm1lacZ null islets
were substantially higher than in controls suggesting that null
beta cells were energy depleted (Fig. 5i, j). ATP levels, deter-
mined by chemiluminescence, were indeed reduced by nearly
twofold in isolated Aldh1b1tm1lacZ null islets (Fig. 5b).
Additionally, a very large number of ribosomal protein genes
were downregulated (ESM Fig. 5e and ESM Table 2). This
also explains the weak expression of PDX1 and NKX6.1 at
the protein level (Fig. 3a–c) despite the upregulation of the
corresponding genes (Fig. 2d and ESM Table 1).
Beta cells are vulnerable to sustained oxidative stress due to
the low expression of antioxidant enzymes [37]. Control mice
maintained or induced expression of several genes involved in
protection from and repair of oxidative damage in the transition
from P1 to the adult stage. This induction did not take place in
the Aldh1b1tm1lacZ null islets (Fig. 5k and ESM Table 1),
consistent with the repression of Nfe2l2 (Fig. 2d) [33].
Staining of islets isolated at week 20 with the live ROS
indicator CM-H2DCFDA indicated a much higher ROS con-
tent in the null islets (Fig. 5l, m). Additionally, immunofluo-
rescence for 4-hydroxynonenal, an indicator of excessive
oxidation of unsaturated fatty acids, showed that
Aldh1b1tm1lacZ null islets were more strongly stained (ESM
Fig. 4k, l). Thus, these findings suggested that Aldh1b1tm1lacZ
null islets are subject to oxidative stress.
Taken together these data showed that Aldh1b1tm1lacZ null
islets are energy depleted and exposed to high oxidative load.
Stimulus-coupling secretion is impaired in the
Aldh1b1tm1lacZ null islets We then investigated the expres-
sion and function of the constituent components of stimulus-
coupling secretion machinery. The RNA Seq data showed that
expression of several K+ and Ca2+ transporters was
misregulated in the Aldh1btm1lacZ islets (ESM Fig. 5b and
ESM Table 2). Additionally, there was a strong upregulation
of several K+ channel genes in Aldh1b1tm1lacZ null islets,
including Kcnj11, a type 2 diabetes risk factor [38] (Fig. 5n
and ESM Table 1), and expression of adenylate cyclases
Adcy4 and Adcy5 was repressed (Fig. 5h and ESM Table 1).
To determine whether defects from membrane depolarisation
and downstream of it contributed to the phenotype, we first
stimulated insulin secretion in isolated islets with 100 μmol/l
tolbutamide, a K+ channel antagonist, in the presence of basal
levels of glucose. Following stimulation, the insulin concen-
tration went from 79.2±8.6 pmol/l to 13.9±0.15 nmol/l in the
wild-type islet medium and reached just 3.27±0.15 nmol/l in
the Aldh1b1tm1lacZ null islet medium, suggesting that the effi-
ciency of events starting with K+-mediated membrane
depolarisation and leading to insulin secretion was compro-
mised (Fig. 5c).
The L-type voltage-gated Ca2+ channel genesCacna1c and
Cacna1d are essential for rodent pancreatic beta cell function
[39, 40] and polymorphisms inCacna1d have been associated
with type 2 diabetes [41]. RNA Seq data showed that Ca2+
channel genes, including Cacna1c and Cacna1d, were upreg-
ulated in the adult Aldh1b1tm1lacZ islets (Fig. 5n and ESM
Table 1). We isolated potential K+ channel defects by directly
stimulating Ca2+ influx in isolated islets with 2 μmol/l of the
specific L-type voltage-sensitive Ca2+ channel agonist
BayK8644 in the presence of basal levels of glucose.
Following stimulation of wild-type islets, insulin concentra-
tion in the medium reached 0.58±0.04 nmol/l but remained
virtually unchanged in the Aldh1b1tm1lacZ null islets, suggest-
ing that increased expression of voltage-gated Ca2+ channels
was not reflected at the protein level and/or that formation of
SGs and exocytosis were affected (Fig. 5d).We then followed,
by fluorescence, changes in the intracellular Ca2+ concentra-
tion in response to glucose stimulation in isolated islets. The
average response was reduced in the week 20 Aldh1b1tm1lacZ
null islets (six mice, n=59) compared with the wild-type con-
trols (four mice, n=34) and this was attributed to a group of
islets (14 out of 59) with very low or negligible response
(Fig. 5o, p). This is consistent with the islet heterogeneity in
the nulls demonstrated by variable levels of NKX6.1, PDX1
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and C-PEP immunostaining (ESM Fig. 4 e–h). Thus, reduced
Ca2+ mobilisation contributes to, but is not solely responsible
for, the observed phenotype.
Regulated insulin exocytosis is the final step of the
stimulus-coupled insulin secretion. Underdeveloped or defec-
tive insulin SGs lead to compromised insulin secretion and
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glucose intolerance [42]. RNA Seq data showed an extensive
deregulation of genes associated with cytoplasmic vesicle and
SG biogenesis, already apparent at P1 and exacerbated at
week 8. A large number of genes associated with SG docking,
regulated exocytosis and GTPase regulation were
misregulated at week 8 (Fig. 6e and ESM Fig. 5c, d, ESM
Tables 1 and 2). Accordingly, we examined the numbers and
morphology of insulin SGs in beta cells of Aldh1b1tm1lacZ null
and control mice at week 8 using transmission electron mi-
croscopy. Electron-dense dark SGs were scored as mature
(type 1) and light-grey SGs as immature (type 2) [43]
(Fig. 6a, b). Affected Aldh1b1tm1lacZ null beta cells contained
a slightly higher total number of SGs but, importantly, the
ratio of immature to mature SGs was increased by more than
twofold (Fig. 6c, d). Since the insulin-to-proinsulin ratio was
not affected in the nulls this was most likely due to changes in
their constitution and biogenesis.
Taken together, these data show that the functionality of
the stimulus-coupling insulin secretion machinery of
Aldh1b1tm1lacZ null beta cells is impaired at multiple levels.
Deterioration of glucose homeostasis with age To under-
stand the substantial hyperglycaemia that developed with
age, we analysed mice at week 52. Glucose tolerance had
further deteriorated and acute insulin secretion was weak
and monophasic (ESM Fig. 6 a, b). Energy depletion and
oxidative stress were again detected in Aldh1b1tm1lacZ null
islets but not in controls. Additionally, increased cell death
was now detected in all null islets but not in controls
(ESM Fig. 6 c–h). Also, proinsulin processing was now less
efficient in the Aldh1b1tm1lacZ nulls and pancreas glucagon
levels were increased (ESM Fig. 3 i, j). As a result of chronic
hyperglycaemia the nulls developed insulin resistance by
week 52 (ESM Fig. 3f). Thus, a combination of persisting
defects, detected earlier, as well as cell death, defective proin-
sulin processing and insulin resistance, cause the exacerbation
of the phenotype in old age.
Discussion
Beta cell dysfunction is a clinical hallmark of the progression
to type 2 diabetes [1]. Studies in humans and rodents have
associated nutrient depletion or environmental insults during
fetal growth with increased susceptibility to adult onset of
metabolic disease and beta cell dysfunction but little is known
about the implicated molecular players [13–15]. The
Aldh1b1tm1lacZ null mice provide a model whereby early
defects in fetal and neonatal stages manifest later in islet func-
tional defects and deterioration of glucose homeostasis, cap-
turing aspects of type 2 diabetes patients. Early defects in null
young adult mice (weeks 6–8) are manifested both molecular-
ly and functionally. Similar islet heterogeneity is encountered
in all mice examined and therefore the phenotype among mice
is relatively uniform. The presence of normal islets mitigates
the phenotype.
Since Aldh1b1 is expressed only in pancreatic progenitors
and briefly in newly formed fetal beta cells, the origin of the
documented islet defects is embryonic. The relatively mild
phenotype could be due to the robust expression of other
ALDH genes including mitochondrial ones in the developing
pancreas (ESM Table 3). Islet heterogeneity may result be-
cause either compensating ALDH genes are not homoge-
neously expressed in the progenitors or shifting the differen-
tiation window of endocrine cells at an earlier time deprives a
subset of differentiating cells from essential signals.
Reduced expression of several transcription factors that play
overlapping roles in establishing and maintaining beta cell
functionality [5, 6, 8–12, 27, 44] was significant at P1 in the
islets of Aldh1b1tm1lacZ null mutants whereas misregulation of
other beta cell functional components was manifested
mostly later. Expression of these transcription factors was
subsequently upregulated in the islets of Aldh1b1tm1lacZ
null adults suggesting an adaptive response. The increase
in beta cell mass is also such a response but does not ad-
dress the functional defects arising from the misregulation
of essential transcription factors. Thus, misregulation of
the beta cell transcription factor network is the primary
result of Aldh1b1 functional inactivation and underlies
Fig. 5 Glucose sensing and stimulus-coupling secretion are impaired in
Aldh1b1tm1lacZ null mice. (a, b) GSIS (a) and total ATP content (b) is
reduced by 13-fold and twofold, respectively, in islets isolated from
Aldh1b1tm1lacZ null mice compared with those isolated from wild-type
mice (n=3) (black bars, wild-type; grey bars, null). (c, d) Stimulation of
insulin release in isolated islets with tolbutamide (c) or BayK8644 (d) is
reduced by fivefold in the Aldh1b1tm1lacZ nulls compared with those
isolated from wild-type mice (n=3) (black bars, wild-type; grey bars,
null). (e–n) Immunofluorescence and gene expression analyses showed
that Aldh1b1tm1lacZ null islets have dramatically reduced GLP1R
expression (f, g), are energy depleted (i, j) and contain high levels of
ROS (l, m). z score heat maps showed misregulated expression of
several genes involved in glycolysis (e), GLP1R-mediated cAMP
production (h) and oxidation defence (k), as well as Ca2+ and K+
channel genes (n) in the Aldh1b1tm1lacZ null islets. (o, p) Increase in
intracellular Ca2+ concentration, calculated as area under the curve in
arbitrary units (AU), following glucose stimulation, is reduced in
Aldh1b1tm1lacZ null islets (o). A subset of Aldh1b1tm1lacZ null islets
(circled in o) shows weak or absent intracellular Ca2+ mobilisation
when compared with a typical wild-type response (wild-type response
is shown in the upper left panel of p, the others represent affected
islets). Horizontal lines in (o) represent the mean and SD; dotted lines
in (p) represent injection time points of stimulation medium (5 min 20 s),
baseline (35 min 20 s) and KCl (40 min 20 s). Results are from three to
five animals per genotype. At least 25 islets per animal were scored or
assayed. Values are means±SEM. **p<0.01 and ***p<0.001 for
indicated comparisons. Heat maps (e, h, k, n), *padj≤0.05: at the left
side of the heat map * refers to comparisons at P1 whereas at the right
side it refers to comparisons at WK 8. Scale bars, 25 μm (g, j) and 80 μm
(m). WK, week; WT, wild-type
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the multiplicity of defects in the islets of Aldh1b1tm1lacZ
null mice.
Availability of low ROS concentrations appears to be crit-
ical for self-renewal of some tissue stem cells [45, 46].
ALDH1B1 activity may participate in ROS level regulation
in the pancreatic progenitors and, therefore, the regulation of
the timing of lineage commitment. Premature commitment
may limit the exposure of progenitors to necessary patterning
signals. Alternatively, ALDH1B1 may modulate metabolic
processes in the mitochondrion and, therefore, affect the levels
of key metabolites necessary for the enzymes employed in
epigenetic regulation of gene expression [47]. It has indeed
been hypothesised that nutrient availability during fetal
growth may lead to epigenetic changes predisposing to diabe-
tes later in life [48]. Metabolomics of pancreatic progenitors
and analysis of epigenetic changes in newly formed beta cells
may clarify the underlying molecular mechanism.
In summary, the findings suggest that deregulation οf the
transcription factors that control beta cell specification, matura-
tion and maintenance is the main early effect of Aldh1b1 inac-
tivation and this occurs at the level of progenitor/committed
endocrine cells during development. This has implications for
the conversion of pluripotent stem cells into functional mature
beta cells and the restoration of dysfunctional beta cells in type
2 diabetes. In addition, the findings indicate that genetic predis-
position to type 2 diabetes may arise from mutations in devel-
opmental genes, which may not necessarily result in an early
postnatal phenotype but manifest later in life.
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